Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria
VIM-type-producing Gram-negative bacteria (GNB) infections are difficult to treat. This is a retrospective single-center study of 34 patients who received cefiderocol for the treatment of VIM-type-producing GNB infections, including 25 <i>Pseudomonas</i> spp., 7 <i>Enterobacterales</i>, and 5 <i>Ach...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2024-09-01
|
| Reeks: | Antibiotics |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2079-6382/13/9/874 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|